Ampersand 2018 Limited Partnership 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-16 4:30 pm Purchase |
2024-10-11 | 13D | Interpace Biosciences, Inc. IDXG |
Ampersand 2018 Limited Partnership | 13,861,386 76.000% |
9,194,720 (+197.03%) |
Filing |
| 2021-11-12 4:31 pm Unchanged |
2021-11-01 | 13D | Interpace Biosciences, Inc. IDXG |
Ampersand 2018 Limited Partnership | 4,666,666 38.900% |
0 (Unchanged) |
Filing |
| 2021-05-18 5:01 pm Unchanged |
2021-05-10 | 13D | Interpace Biosciences, Inc. IDXG |
Ampersand 2018 Limited Partnership | 4,666,666 39.100% |
0 (Unchanged) |
Filing |
| 2021-01-19 4:13 pm Unchanged |
2021-01-07 | 13D | Interpace Biosciences, Inc. IDXG |
Ampersand 2018 Limited Partnership | 4,666,666 39.300% |
0 (Unchanged) |
Filing |